All News about Phasebio Pharmaceuticals Inc![]() ![]()
PhaseBio Might Have To Return Global Rights To Its Lead Program
September 28, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]()
Stocks That Hit 52-Week Lows On Tuesday
November 01, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Why Senti Biosciences Shares Jumped Over 50%; Here Are 79 Biggest Movers From Yesterday
September 30, 2022
Via Benzinga
![]() ![]()
12 Health Care Stocks Moving In Wednesday's Intraday Session
September 28, 2022
Via Benzinga
![]()
Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday
September 29, 2022
Via Benzinga
![]() ![]() ![]()
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2022
September 28, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
Phasebio Pharmaceuticals Inc (NQ: PHAS )All News about Phasebio Pharmaceuticals Inc
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|